Brought to you by:
Empowering vascular surgery to promote five pivotal healthcare bills before Congress
Welcome back to Government Grand Rounds, a campaign aimed at expanding vascular surgeons’ understanding of—and comfort with—the SVS’ many advocacy tools. In the dynamic landscape of healthcare, the promotion of positive change and the advancement of our profession require more…
Coding and complex PAD: Register today for two SVS courses
Limited spots remain open for two popular SVS courses coming in October: the Complex Peripheral Vascular Interventions (CPVI) Skills Course on Oct. 1–2 and the Coding and Reimbursement Workshop (with optional half-day evaluation and management coding workshop) on Oct. 16–17.…
Step off Friday for SVS Vascular Health Step Challenge
The month of September begins Friday and with it, the SVS Foundation’s Vascular Health Step Challenge. The initiative challenges participants to walk 60 miles—representing the 60,000 miles of blood vessels in the human body—throughout the month, which is National Peripheral…
First US patient enrolled in SOCRATES short neck AAA trial
The first U.S. patient has been treated as part of the SOCRATES trial (Short neck AAA randomized trial—ESAR and FEVAR), which compares the safety and performance of endosuture aneurysm repair (ESAR) with fenestrated endovascular aneurysm repair (FEVAR) for the treatment…
The price of a cup of coffee
In the wake of the coverage of inappropriate vascular interventions in the mainstream press, guest editorialist Adam Tanious, MD, tackles the thorny issue of interactions with industry “reps”—particularly among younger surgeons. Many of us in the surgical community have had…
Endovascular stablization system for infrarenal AAAs gains FDA Fast Track designation
Nectero Medical announced that the Food and Drug Administration (FDA) has granted Fast Track designation for the Nectero Endovascular Aneurysm Stabilization Treatment (Nectero EAST) system to treat patients with infrarenal abdominal aortic aneurysms (AAAs) of maximum diameter 3.5–5cm. The company…
Venous stenting and the IVC: ‘Persistent problems’ in the setting of post-thrombotic syndrome
The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous Stenting Summit that took place during VAM 2023 in National Harbor, Maryland (June 14–17). The issue…
Congress considers incremental steps towards Medicare payment reform
There is no doubt that the Medicare payment system needs reform. At this moment, the SVS is aiming to inspire reform through all facets of effective advocacy. This takes place incrementally by raising Congressional awareness of the issues that physicians…
First patient treated in global strategic collaboration involving Cydar Maps technology
Cydar Medical has announced the successful treatment of the first patient in a strategic collaboration with Medtronic. The collaboration, which spans 40 sites across the U.S., UK and Europe, involves the integration of the company’s Cydar Maps software with Medtronic’s…
Clinical performance of Human Acellular Vessel amid war in Ukraine presented at military research symposium
Clinical outcomes of Humacyte’s investigational Human Acellular Vessel (HAV) were presented at the Military Health System Research Symposium in Kissimmee, Florida (Aug. 14–17), following a year-long humanitarian program in Ukraine. The bioengineered, implantable human tissue-based device was provided to five…